Interleukin (IL-2) Treatment
Led by one of the nation’s most experienced IL-2 oncologists, Dr. Gerald Miletello, our highly skilled medical team is dedicated to caring for patients undergoing
PROLEUKIN® IL-2 therapy. IL-2 has been used for more than 15 years
in the treatment of metastatic melanoma and for more than 20 years in
the treatment of metastatic kidney cancer (renal cell carcinoma). Patient
outcomes have surpassed national averages and we are creating success
stories every day.
How IL-2 Therapy Works
Studies have shown that IL-2 therapy is effective for treating these cancers,
which traditionally have low survival rates. A form of immunotherapy,
IL-2 uses the body’s natural immune system to fight cancer, as opposed
to chemotherapy, which directly attacks the cancer itself.
It is administered intravenously at the hospital and patients can go home
once the injection therapy is complete. After your first course of IL-2
therapy, which takes about two months, our team of caregivers may be able
to determine if your tumors have shrunk. Depending on your state of health
and the success of the first course of treatment, a second course of therapy
may be recommended.
IL-2 Treatment Center
Our cancer center includes spacious, private rooms appointed with wood
floors, microwaves, refrigerators and television. Newly added space for
family members offers quiet accommodations for resting, reading or consulting
with your loved one's team of caregivers. Our campus amenities include
free valet parking, a full-service café, courtyards, coffee shop,
pharmacy and gift shop.
Call (225) 237-1600 to speak with an expert who can answer your questions,
address your concerns and provide support as you go through diagnosis,
treatment and recovery.